An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

Clinical trial NCT06352502 · UNKNOWN

Trial details

NCT number: NCT06352502
Sponsor: Tang-Du Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

EGF-R Positive Non-Small Cell Lung Cancer CNS Metastases

Start date: 2022-01-28
Primary completion: 2024-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.